What we should know in managing infertility related to endometriosis?

What we should know in managing infertility related to endometriosis? - Engin   Aydin By Engin Aydin

Infertility management in endometriosis: basic facts revisited


Key Points Lay Summary

Endometriosis and atherosclerotic cardiovascular disease

Endometriosis and atherosclerotic cardiovascular disease - Selma   Oransay By Selma Oransay

Early diagnosis and treatment of endometriosis could help to reduce the incidence of atherosclerotic cardiovascular disease if this relationship is certain.


Key Points Lay Summary

CXCR4 or CXCR7 antagonists as novel therapies for endometriosis

CXCR4 or CXCR7 antagonists as novel therapies for endometriosis - Dr. Youngran   Park By Dr. Youngran Park

Blocking CXCR4 and CXCR7 reduces engraftment of bone marrow-derived stem cells into the endometriosis


Key Points Lay Summary

A nonhormonal treatment of endometriosis: Dichloroacetate

A nonhormonal treatment of endometriosis: Dichloroacetate - Irem  Onur By Irem Onur

Oral administration of dichloroacetate reduced the size of endometriosis lesions in a mouse model.


Key Points Lay Summary

What do Women with Endometriosis Think About the Medical Profession?

What do Women with Endometriosis Think About the Medical Profession? - Özge  Özkaya By Özge Özkaya

Study describes factors associated with a negative perception of the medical profession among women with endometriosis.


Key Points Lay Summary

Endometriosis signaling: the role of IL-34

Endometriosis signaling: the role of IL-34 - Yu  Yu By Yu Yu

IL-34 as a future target in endometriosis treatment


Key Points Lay Summary

A comprehensive review on the etiopathogenesis of endometriosis

A comprehensive review on the etiopathogenesis of endometriosis - Engin   Aydin By Engin Aydin

A single etiopathogenetic explanatory model is not sufficient for endometriosis


Key Points Lay Summary

Endometriosis and ovarian reserve

Endometriosis and ovarian reserve  - Hale Goksever  Celik By Hale Goksever Celik

The follicular output rate (FORT) and the number of metaphase-II oocytes decrease due to endometriosis, regardless of age, antral follicle count and anti-Müllerian hormone.


Key Points Lay Summary
‹ First  < 23 4 >  Last ›